Rhine Biotech (002166.SZ) plans to collectively reduce its holdings by no more than 0.14% of the shares held by some board members at the high level.

ChiNext Finance APP News, Rayon Biochemical (002166.SZ) announced that Mr. Xie Yongfu, Chairman and General Manager of the company, Mr. Bai Yu, Director and Vice General Manager, Ms. Zheng Hui, Director and Vice General Manager and Chief Financial Officer, and Mr. Luo Huayang, Vice General Manager and Company Secretary (referred to as "the above-mentioned personnel") collectively hold 4.074 million shares of the company, accounting for 0.56% of the total share capital of the company (the total share capital is calculated excluding the shares repurchased in the company's repurchase special account, the same below). The above-mentioned personnel plan to reduce their holdings of the company's shares by a total of 1.0185 million shares (representing 0.14% of the total share capital of the company) through centralized bidding within 3 months after 15 trading days from the date of the announcement.